Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and ...

India experiences the world’s absolute burden of at least 11 NTDs, including hookworm, dengue, lymphatic filariasis, leprosy, ...

Don’t look now but the Dengvaxia cases and controversy are beginning to boomerang and may end up landing at the feet or face of those who started it.

The Department of Justice (DOJ) has ordered the withdrawal of cases against former Department of Health (DOH) secretary and ...

This came a week after Dengvaxia manufacturer Sanofi warned that the vaccine may cause severe diseases in the long run for those who have not been infected by dengue prior to the vaccination.—LDF, GMA ...

Researchers believe the innovative idea holds immense promise for tackling a wide range of diseases including cancer through ...

The Public Attorney's Office has asked the Department of Justice (DOJ) to reconsider its January 10, 2025 resolution ordering the withdrawal of criminal ...

THE Public Attorney’s Office (PAO) has filed a motion for reconsideration with the Department of Justice (DOJ), seeking the ...

Serum Institute of India is planning to introduce chikungunya and monkeypox vaccines in about a year and a half and a dengue vaccine in approximately three years. The company is focusing on vaccine ...

With the Department of Justice withdrawing the criminal cases against former health secretary Janette Garin and two other ...